Unlocking the Commercial Potential of Psychedelics
PSYCH is a data and insights platform for the psychedelic healthcare industry.
The Psychedelics as Medicine Report: Fourth Edition
The leading resource for comprehensive insight and
intelligence on the global psychedelics industry.
Follow us on Twitter
Decision makers from across psychedelic healthcare converged at PSYCH Symposium: London 2022, to shape the future of psychedelic medicine.
In this series of short interviews, thought leaders reveal why it was Europe’s premier psychedelic healthcare event: https://youtu.be/ArB82kAHClQ
'It begins with an opening and a loosening of the mind...The action is one of insight — revelation, self-understanding, perspective change.'
@RCarhartHarris spoke with @TheTimes on how psychedelic medicines are transforming psychiatry:
Are psychedelic drugs the answer to the mental health crisis?
Steve Shorney is a serious man, quiet and thoughtful. But the first time he took psilocybin he could not stop ...
www.thetimes.co.uk
‘A big component is identifying the payer...You could make the most beautiful drug in the world and take it to market, but if no one can afford it, it is not going to work.’
@ApexLabsLtd's CEO on the commercialisation of psychedelic healthcare: $APEX
Treating PTSD at home with psilocybin - Apex Labs
Apex Labs received approval for its study to treat PTSD with psilocybin – with patients taking the psychedelic medicine at home.
bit.ly
Psychedelic research should 'link mechanisms downstream of receptor activation to adaptive changes in the function of circuits relevant to mental health.'
@NIMHgov outlines guidance and priorities for grants into psychedelic science: https://grants.nih.gov/grants/guide/notice-files/NOT-MH-23-125.html?utm_source=dlvr.it&utm_medium=twitter
'Mental illness is now the biggest health burden in Australia. Treatment innovation has stalled...Psilocybin and MDMA produce profound improvements.'
@ProfDavidNutt of @Awakn_ls spoke with @Australian on the efficacy of psychedelic medicine: $AWKN $AWKNF
Australia's approach to psychedelics 'ignorant' in mental health crisis
“Mental illness is now the biggest health burden in Australia. Treatment innovation has stalled and we’re ...
bit.ly